Jennifer Michaelson - Jun 20, 2023 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
Chief Development Officer
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Stock symbol
CGEM
Transactions as of
Jun 20, 2023
Transactions value $
-$3,080
Form type
4
Date filed
6/21/2023, 04:17 PM
Previous filing
Jun 14, 2023
Next filing
Dec 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Sale -$3.08K -238 -0.26% $12.94 90K Jun 20, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.